These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20453069)

  • 41. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient selection for thromboprophylaxis in medical inpatients.
    Bozzato S; Squizzato A; Donadini MP; Guasti L; Dentali F; Ageno W
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1639-47. PubMed ID: 24215194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of residual risk factors for the development of venous thromboembolism in medical inpatients receiving subcutaneous heparin therapy for prophylaxis.
    Kato S; Shimada YJ; Friedmann P; Kashan G; Husk G; Bergmann SR
    Coron Artery Dis; 2012 Jun; 23(4):294-7. PubMed ID: 22421548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood transfusion, bleeding, anemia, and survival in patients with acute myocardial infarction: FAST-MI registry.
    Ducrocq G; Puymirat E; Steg PG; Henry P; Martelet M; Karam C; Schiele F; Simon T; Danchin N
    Am Heart J; 2015 Oct; 170(4):726-734.e2. PubMed ID: 26386796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
    Aikens GB; Rivey MP; Hansen CJ
    Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Venous thromboembolic prophylaxis in hospitalized medical patients.
    Stark JE; Kilzer WJ
    Ann Pharmacother; 2004 Jan; 38(1):36-40. PubMed ID: 14742790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline.
    Lederle FA; Zylla D; MacDonald R; Wilt TJ
    Ann Intern Med; 2011 Nov; 155(9):602-15. PubMed ID: 22041949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of falls and bleeding in elderly patients with acute venous thromboembolism.
    Kämpfen P; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Cornuz J; Banyai M; Egloff M; Aschwanden M; Bounameaux H; Rodondi N; Aujesky D
    J Intern Med; 2014 Oct; 276(4):378-86. PubMed ID: 24645727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemoprophylaxis for venous thromboembolism in otolaryngology.
    Bahl V; Shuman AG; Hu HM; Jackson CR; Pannucci CJ; Alaniz C; Chepeha DB; Bradford CR
    JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):999-1005. PubMed ID: 25275427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model.
    Maynard GA; Morris TA; Jenkins IH; Stone S; Lee J; Renvall M; Fink E; Schoenhaus R
    J Hosp Med; 2010 Jan; 5(1):10-8. PubMed ID: 19753640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive geriatric assessment predicts mortality and adverse outcomes in hospitalized older adults.
    Avelino-Silva TJ; Farfel JM; Curiati JA; Amaral JR; Campora F; Jacob-Filho W
    BMC Geriatr; 2014 Dec; 14():129. PubMed ID: 25464932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Venous thromboembolism prevention in acutely ill nonsurgical patients.
    Brophy DF; Dougherty JA; Garrelts JC; Parish RC; Rivey MP; Stumpf JL; Taylor CT; Mathis AS
    Ann Pharmacother; 2005; 39(7-8):1318-24. PubMed ID: 15941823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of bleeding associated with use of systemic thromboembolic prophylaxis during laparoscopic cholecystectomy.
    Persson G; Strömberg J; Svennblad B; Sandblom G
    Br J Surg; 2012 Jul; 99(7):979-86. PubMed ID: 22628016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a retrospective single-center cohort study in Japan.
    Arakaki D; Iwata M; Terasawa T
    Thromb J; 2024 Mar; 22(1):31. PubMed ID: 38549086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment.
    Darzi AJ; Karam SG; Spencer FA; Spyropoulos AC; Mbuagbaw L; Woller SC; Zakai NA; Streiff MB; Gould MK; Cushman M; Charide R; Etxeandia-Ikobaltzeta I; Germini F; Rigoni M; Agarwal A; Morsi RZ; Akl EA; Iorio A; Schünemann HJ
    Blood Adv; 2020 Jun; 4(12):2557-2566. PubMed ID: 32542391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent population.
    Wilkinson KS; Sparks AD; Gergi M; Repp AB; Al-Samkari H; Thomas R; Roetker NS; Zakai NA
    Res Pract Thromb Haemost; 2024 May; 8(4):102441. PubMed ID: 38953050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.